Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness

Takafumi Matsumoto, Hiromasa Inoue, Yosuke Sato, Yoshihiro Kita, Takako Nakano, Naotaka Noda, Miyuki Eguchi-Tsuda, Atsushi Moriwaki, Keiko Kan-o, Koichiro Matsumoto, Takao Shimizu, Hiromichi Nagasawa, Shohei Sakuda, Yoichi Nakanishi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Acidic mammalian chitinase is upregulated in response to allergen exposure in the lung. We investigated the effects of chitinase inhibitors, allosamidin (Allo) and demethylallosamidin (Dma), on asthmatic responses. Mice were subjected to IL-13 instillation into the airways or to ovalbumin sensitization plus exposure with or without treatment of Allo or Dma. Airway hyperresponsiveness (AHR) and inflammation were evaluated. Allo and Dma attenuated airway eosinophilia and the upregulation of eotaxin after IL-13 instillation, while Dma, but not Allo, suppressed AHR in IL-13-induced asthma. Allo or Dma suppressed the elevated chitinase activity in BAL fluids after IL-13 to similar levels. The bronchoprotective PGE2 levels in BAL fluids were elevated after IL-13 instillation. Allo, but not Dma, suppressed the overproduction of PGE2 and the expression of COX-2 and PGE synthase-1 induced by IL-13. In ovalbumin-induced asthma, Dma suppressed AHR more strongly than Allo. These findings suggest that Dma attenuates asthmatic responses induced by IL-13 without affecting PGE2 synthesis. Dma may have potential as therapeutic agents for asthma.

Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume390
Issue number1
DOIs
Publication statusPublished - Dec 4 2009

Fingerprint

allosamidin
Chitinases
Interleukin-13
Inflammation
Dinoprostone
Dimercaprol
Asthma
Ovalbumin
Fluids
Eosinophilia
Prostaglandins E
Allergens

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness. / Matsumoto, Takafumi; Inoue, Hiromasa; Sato, Yosuke; Kita, Yoshihiro; Nakano, Takako; Noda, Naotaka; Eguchi-Tsuda, Miyuki; Moriwaki, Atsushi; Kan-o, Keiko; Matsumoto, Koichiro; Shimizu, Takao; Nagasawa, Hiromichi; Sakuda, Shohei; Nakanishi, Yoichi.

In: Biochemical and Biophysical Research Communications, Vol. 390, No. 1, 04.12.2009, p. 103-108.

Research output: Contribution to journalArticle

Matsumoto, T, Inoue, H, Sato, Y, Kita, Y, Nakano, T, Noda, N, Eguchi-Tsuda, M, Moriwaki, A, Kan-o, K, Matsumoto, K, Shimizu, T, Nagasawa, H, Sakuda, S & Nakanishi, Y 2009, 'Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness', Biochemical and Biophysical Research Communications, vol. 390, no. 1, pp. 103-108. https://doi.org/10.1016/j.bbrc.2009.09.075
Matsumoto, Takafumi ; Inoue, Hiromasa ; Sato, Yosuke ; Kita, Yoshihiro ; Nakano, Takako ; Noda, Naotaka ; Eguchi-Tsuda, Miyuki ; Moriwaki, Atsushi ; Kan-o, Keiko ; Matsumoto, Koichiro ; Shimizu, Takao ; Nagasawa, Hiromichi ; Sakuda, Shohei ; Nakanishi, Yoichi. / Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness. In: Biochemical and Biophysical Research Communications. 2009 ; Vol. 390, No. 1. pp. 103-108.
@article{79c3c4a477464bc2b9789fa4219a0814,
title = "Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness",
abstract = "Acidic mammalian chitinase is upregulated in response to allergen exposure in the lung. We investigated the effects of chitinase inhibitors, allosamidin (Allo) and demethylallosamidin (Dma), on asthmatic responses. Mice were subjected to IL-13 instillation into the airways or to ovalbumin sensitization plus exposure with or without treatment of Allo or Dma. Airway hyperresponsiveness (AHR) and inflammation were evaluated. Allo and Dma attenuated airway eosinophilia and the upregulation of eotaxin after IL-13 instillation, while Dma, but not Allo, suppressed AHR in IL-13-induced asthma. Allo or Dma suppressed the elevated chitinase activity in BAL fluids after IL-13 to similar levels. The bronchoprotective PGE2 levels in BAL fluids were elevated after IL-13 instillation. Allo, but not Dma, suppressed the overproduction of PGE2 and the expression of COX-2 and PGE synthase-1 induced by IL-13. In ovalbumin-induced asthma, Dma suppressed AHR more strongly than Allo. These findings suggest that Dma attenuates asthmatic responses induced by IL-13 without affecting PGE2 synthesis. Dma may have potential as therapeutic agents for asthma.",
author = "Takafumi Matsumoto and Hiromasa Inoue and Yosuke Sato and Yoshihiro Kita and Takako Nakano and Naotaka Noda and Miyuki Eguchi-Tsuda and Atsushi Moriwaki and Keiko Kan-o and Koichiro Matsumoto and Takao Shimizu and Hiromichi Nagasawa and Shohei Sakuda and Yoichi Nakanishi",
year = "2009",
month = "12",
day = "4",
doi = "10.1016/j.bbrc.2009.09.075",
language = "English",
volume = "390",
pages = "103--108",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness

AU - Matsumoto, Takafumi

AU - Inoue, Hiromasa

AU - Sato, Yosuke

AU - Kita, Yoshihiro

AU - Nakano, Takako

AU - Noda, Naotaka

AU - Eguchi-Tsuda, Miyuki

AU - Moriwaki, Atsushi

AU - Kan-o, Keiko

AU - Matsumoto, Koichiro

AU - Shimizu, Takao

AU - Nagasawa, Hiromichi

AU - Sakuda, Shohei

AU - Nakanishi, Yoichi

PY - 2009/12/4

Y1 - 2009/12/4

N2 - Acidic mammalian chitinase is upregulated in response to allergen exposure in the lung. We investigated the effects of chitinase inhibitors, allosamidin (Allo) and demethylallosamidin (Dma), on asthmatic responses. Mice were subjected to IL-13 instillation into the airways or to ovalbumin sensitization plus exposure with or without treatment of Allo or Dma. Airway hyperresponsiveness (AHR) and inflammation were evaluated. Allo and Dma attenuated airway eosinophilia and the upregulation of eotaxin after IL-13 instillation, while Dma, but not Allo, suppressed AHR in IL-13-induced asthma. Allo or Dma suppressed the elevated chitinase activity in BAL fluids after IL-13 to similar levels. The bronchoprotective PGE2 levels in BAL fluids were elevated after IL-13 instillation. Allo, but not Dma, suppressed the overproduction of PGE2 and the expression of COX-2 and PGE synthase-1 induced by IL-13. In ovalbumin-induced asthma, Dma suppressed AHR more strongly than Allo. These findings suggest that Dma attenuates asthmatic responses induced by IL-13 without affecting PGE2 synthesis. Dma may have potential as therapeutic agents for asthma.

AB - Acidic mammalian chitinase is upregulated in response to allergen exposure in the lung. We investigated the effects of chitinase inhibitors, allosamidin (Allo) and demethylallosamidin (Dma), on asthmatic responses. Mice were subjected to IL-13 instillation into the airways or to ovalbumin sensitization plus exposure with or without treatment of Allo or Dma. Airway hyperresponsiveness (AHR) and inflammation were evaluated. Allo and Dma attenuated airway eosinophilia and the upregulation of eotaxin after IL-13 instillation, while Dma, but not Allo, suppressed AHR in IL-13-induced asthma. Allo or Dma suppressed the elevated chitinase activity in BAL fluids after IL-13 to similar levels. The bronchoprotective PGE2 levels in BAL fluids were elevated after IL-13 instillation. Allo, but not Dma, suppressed the overproduction of PGE2 and the expression of COX-2 and PGE synthase-1 induced by IL-13. In ovalbumin-induced asthma, Dma suppressed AHR more strongly than Allo. These findings suggest that Dma attenuates asthmatic responses induced by IL-13 without affecting PGE2 synthesis. Dma may have potential as therapeutic agents for asthma.

UR - http://www.scopus.com/inward/record.url?scp=70349964407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349964407&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.09.075

DO - 10.1016/j.bbrc.2009.09.075

M3 - Article

C2 - 19782048

AN - SCOPUS:70349964407

VL - 390

SP - 103

EP - 108

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -